Synthetic Minds Newsletter

Synthetic Minds | AI Just Took the Decision Seat Between You and the Drug

The FDA opened real-time AI monitoring of oncology trials. Nature Medicine published a model that replaces BMI. DeepMind unveiled an AI co-clinician. FDA approved the first PROTAC, gated by a genomic test. Five control points, one direction — AI is now sitting between the patient and the drug today.

Synthetic Minds | Stablecoins Just Sent Wall Street the Calendar Invite

In a seven-day window, MoonPay, Stripe, Visa and Meta shipped agent-authorized stablecoin rails to production while DTCC named July and October launch dates for its SEC-backed tokenization service. Two halves of one payment bridge moved. Leaders treating this as crypto news will misread their stack.

Synthetic Minds | The Agent Got a Wallet. Commerce Will Never Be the Same.

On 30 April Cloudflare and Stripe launched an open protocol giving AI agents identity, authorization and payment capabilities, no human required. This is the infrastructure making agentic commerce real at production scale, the moment agents stopped being tools and became autonomous economic actors.

Synthetic Minds | Five Tech Giants Just Split Drug Discovery

OpenAI shipped GPT-Rosalind. Amazon launched Bio Discovery. Anthropic acquired Coefficient Bio. Isomorphic Labs got FDA Phase 1 clearance. Lilly built a 1,016-GPU AI factory. Five architectures, zero interoperability. The platform you pick determines who owns the intelligence beneath your science.

Synthetic Minds | Vibe Coding Works. If You Have the Discipline.

I built production software in five weeks without writing a line of code. Then one AI coding session destroyed three weeks of work. Here's what I learned about vibe coding that actually works for business leaders — and the eight-point blueprint for doing it with discipline, not hype.

Synthetic Minds | Pharma Companies Are Quietly Becoming Compute Companies

Roche now runs 3,500+ NVIDIA GPUs on premises for drug discovery — pharma's largest GPU cluster. Lilly committed $2.75B to an AI platform that generates drugs. Insilico's CEO says the shift is from licensing molecules to licensing infrastructure. Pharma is not adopting technology. It is becoming it.

Synthetic Minds | The Internet is Breaking. We Built a Filter for What Survives

AI-generated content has drowned every feed, search result and inbox. Finding something worth reading takes longer than reading it. Futurwise rebuilt from the ground up: 84 granular categories, tiered source access from mainstream to academic, and a personal noise filter for any content you drop in.

Synthetic Minds | $14 Trillion and $1.6 Million Are Building the Same Bridge

BlackRock's $150 billion digital-asset AUM backs Fink's vision of universal digital wallets holding ETFs and tokenized bonds. The same week, MoonPay, Coinbase, PayPal, and Ripple launched an open wallet standard for AI agents. Two sides of the same bridge, and neither needs advertising to function.

Synthetic Minds | Four AI Signals in One Week. Most Organizations Saw Zero.

In seven days, Google put AI into 20,000+ industrial robots. TurboQuant compressed LLMs 6x with zero accuracy loss. Anthropic leaked a step-change model with unprecedented cybersecurity risks. Taalas hardwired an LLM into a chip at 17,000 tokens per second. Most leadership teams missed every signal.

Synthetic Minds | Capital Chose Renewables, Politics Is Playing Catch-Up

Despite political headwinds, capital markets are rebuilding the grid around renewables. 814 GW of solar and wind installed globally in 2025, a record 86 GW of clean US capacity planned for 2026, and the biggest oil disruption in history make the case: resilience, not ideology, drives the transition.